Macular density alterations in myopic choroidal neovascularization and the effect of anti-VEGF on it. [PDF]
Mao JB +9 more
europepmc +1 more source
Ten-year outcomes of intravitreal injection of ranibizumab for the treatment of myopic choroidal neovascularization. [PDF]
Kung YH, Peng KL, Shih LY, Wu TT.
europepmc +1 more source
Prediction of Visual Acuity in Pathologic Myopia with Myopic Choroidal Neovascularization Treated with Anti-Vascular Endothelial Growth Factor Using a Deep Neural Network Based on Optical Coherence Tomography Images. [PDF]
Yang M +8 more
europepmc +1 more source
Ten-Year Outcomes of Intravitreal Bevacizumab for Myopic Choroidal Neovascularization: Analysis of Prognostic Factors. [PDF]
Mallone F +7 more
europepmc +1 more source
The Long-Term Evolution of Macular Retinoschisis in Eyes with Myopic Choroidal Neovascularization Treated with Anti-Vascular Endothelial Growth Factors. [PDF]
Tsai HH, Chen FT.
europepmc +1 more source
Baseline predictors for good visual gains after anti-vascular endothelial growth factor therapy for myopic choroidal neovascularization. [PDF]
Hsu CR +5 more
europepmc +1 more source
Retinal Predictors of Visual Outcome and Recurrence in Naïve Myopic Choroidal Neovascularization Patients. [PDF]
Inferrera L +6 more
europepmc +1 more source
Real-World Anti-Vascular Endothelial Growth Factor Therapy Outcomes in Myopic Choroidal Neovascularization. [PDF]
Bhatia D +4 more
europepmc +1 more source
Ilias Georgalas, Alexandros A Rouvas, Dimitrios A Karagiannis, Athanasios I Kotsolis, Ioannis D LadasDepartment of Ophthalmology, Medical School of Athens University, Athens, GreeceAbstract: This is a case report of a 83-year-old man with choroidal ...
Alexandros A Rouvas +4 more
core
COMPARISON OF CHARACTERISTICS AND TREATMENT OUTCOMES OF TYPE 1 AND TYPE 2 MYOPIC CHOROIDAL NEOVASCULARIZATION AFTER ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY. [PDF]
Tew TB +12 more
europepmc +1 more source

